BridgeMD
New treatment option for Dementia
Official title Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia
ClinicalTrials.gov ID: NCT05799001
What this study is testing
- What it's testing
- It is estimated that the prevalence of dementia in France is 5% for people over 65 years of age and that this increases to 18% for people over 75 years of age. Behavioral disorders are frequent in patients with dementia and are the main cause of institutionalization, representing up to 50% of cases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Institutionalized patient (male or female) over 65 years of age ;
- Patient with behavioral problems, as measured by an NPI-ES ≥ 4 on any item and an NPI-ES impact scale ≥ 3 ;
- Patient able to mobilize the upper body at a minimum (arms, trunk, head);
- Medication (antipsychotics, antidepressants, anxiolytics and related hypnotics) without major modification for at least 30 days prior to inclusion...
- Possibility of including patients under guardianship or curatorship;
You likely can't join if
- Inability of the patient to follow the sessions (e.g., major visual/auditory disabilities), difficult follow-up, or any other reason at the...
- Inability of the health care team to complete the NPI-ES questionnaire for the patient;
- Patient has a concurrent psychiatric disorder (e.g., bipolar disorder, schizophrenia, or other).
See the full eligibility criteria
- Institutionalized patient (male or female) over 65 years of age ;
- Patient with behavioral problems, as measured by an NPI-ES ≥ 4 on any item and an NPI-ES impact scale ≥ 3 ;
- Patient able to mobilize the upper body at a minimum (arms, trunk, head);
- Medication (antipsychotics, antidepressants, anxiolytics and related hypnotics) without major modification for at least 30 days prior to inclusion after medical advice;
- Possibility of including patients under guardianship or curatorship;
- Patient affiliated to a social security plan;
- Obtaining consent from the patient or legal representative.
- Inability of the patient to follow the sessions (e.g., major visual/auditory disabilities), difficult follow-up, or any other reason at the discretion of the investigator;
- Inability of the health care team to complete the NPI-ES questionnaire for the patient;
- Patient has a concurrent psychiatric disorder (e.g., bipolar disorder, schizophrenia, or other).
The study team makes the final eligibility decision.
Where it's taking place
- Craponne-sur-Arzon, France
- Le Puy-en-Velay, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Craponne-sur-Arzon, France; Le Puy-en-Velay, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.